MedTrace Logo

Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response

NCT05851313 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2023-05-12

No results posted yet for this study

Summary

The goal of this clinical trial study is to investigate the role of anthropometric indices and Vit-D supplementation on BioNTech, Pfizer vaccine side effect and immunoglobulin G response against SARS-CoV-2 in individuals infected with COVID-19.

The main question\[s\] it aims to answer are:

1. BMI has role in reduce BioNTech, Pfizer vaccine side effect
2. BMI has role in improve IgG titer
3. Vit-D supplementation has role in reduce BioNTech, Pfizer vaccine side effect
4. Vit-D supplementation has role in improve IgG titer

Conditions

  • COVID-19 Respiratory Infection

Interventions

COMBINATION_PRODUCT

Vitamin-D

The intervention group received 600IU of vitamin D supplements every day, one hour after breakfast for 14-16 weeks.

Sponsors & Collaborators

  • Sulaimany Polytechnic university

    lead OTHER

Principal Investigators

  • Hawal F Lateef, Msc · 1- Nursing Department, Kalar Technical College, Sulaimani polytechnic university, Sulaimani, Iraq

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-05
Primary Completion
2023-02-10
Completion
2023-04-07
FDA Drug
Yes
FDA Device
Yes

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05851313 on ClinicalTrials.gov